tiprankstipranks
TG Therapeutics (TGTX)
NASDAQ:TGTX
US Market
TGTX
TG Therapeutics
RESEARCH TOOLSreports
Want to see TGTX full AI Analyst Report?

TG Therapeutics (TGTX) Ratios

2,130 Followers

TG Therapeutics Ratios

TGTX's free cash flow for Q1 2026 was $0.84. For the 2026 fiscal year, TGTX's free cash flow was decreased by $ and operating cash flow was $0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.81 4.10 6.25 5.92 3.16
Quick Ratio
 5.12 3.29 5.03 5.18 3.16
Cash Ratio
 2.36 0.51 1.98 1.73 1.92
Solvency Ratio
 0.49 1.08 0.07 0.08 -1.65
Operating Cash Flow Ratio
 -0.07 -0.16 -0.45 -0.58 -3.31
Short-Term Operating Cash Flow Coverage
 -7.66 -23.73 0.00 0.00 0.00
Net Current Asset Value
$ 141.26M$ 215.53M$ 211.03M$ 148.86M$ 33.29M
Leverage Ratios
Debt-to-Assets Ratio
 0.49 0.25 0.44 0.34 0.43
Debt-to-Equity Ratio
 1.29 0.40 1.14 0.69 1.42
Debt-to-Capital Ratio
 0.56 0.29 0.53 0.41 0.59
Long-Term Debt-to-Capital Ratio
 0.56 0.28 0.52 0.38 0.55
Financial Leverage Ratio
 2.62 1.64 2.60 2.05 3.30
Debt Service Coverage Ratio
 16.85 17.07 1.98 2.04 -20.91
Interest Coverage Ratio
 5.41 4.61 1.75 1.64 -21.42
Debt to Market Cap
 0.13 0.06 0.06 0.04 0.04
Interest Debt Per Share
 5.41 1.99 1.91 0.87 0.69
Net Debt to EBITDA
 1.98 1.35 1.48 0.68 0.09
Profitability Margins
Gross Profit Margin
83.04%83.66%88.30%93.95%90.48%
EBIT Margin
22.37%21.76%15.08%10.99%-7670.41%
EBITDA Margin
22.40%21.80%15.17%11.17%-7651.92%
Operating Profit Margin
21.35%20.01%12.74%8.83%-7838.99%
Pretax Profit Margin
17.46%17.43%7.78%5.59%-8036.34%
Net Profit Margin
65.95%72.56%7.11%5.42%-8036.34%
Continuous Operations Profit Margin
65.95%72.56%7.11%5.42%-8036.34%
Net Income Per EBT
377.72%416.41%91.36%97.01%100.00%
EBT Per EBIT
81.80%87.08%61.04%63.31%102.52%
Return on Assets (ROA)
30.21%42.06%4.05%3.84%-115.62%
Return on Equity (ROE)
87.36%69.01%10.52%7.90%-382.02%
Return on Capital Employed (ROCE)
11.14%13.56%8.61%7.48%-155.53%
Return on Invested Capital (ROIC)
11.13%13.54%7.85%7.22%-153.80%
Return on Tangible Assets
30.21%42.06%4.05%3.85%-116.10%
Earnings Yield
8.24%10.39%0.53%0.52%-13.97%
Efficiency Ratios
Receivables Turnover
 1.79 2.02 2.55 4.57 0.00
Payables Turnover
 0.80 0.94 0.00 0.00 0.00
Inventory Turnover
 0.92 0.80 0.35 0.35 0.00
Fixed Asset Turnover
 108.06 98.17 46.01 29.03 0.26
Asset Turnover
 0.46 0.58 0.57 0.71 0.01
Working Capital Turnover Ratio
 1.02 1.29 0.89 1.23 0.01
Cash Conversion Cycle
 143.41 246.53 1.19K 1.11K 0.00
Days of Sales Outstanding
 204.32 181.01 143.32 79.81 0.00
Days of Inventory Outstanding
 396.61 455.14 1.05K 1.03K 0.00
Days of Payables Outstanding
 457.52 389.62 0.00 0.00 0.00
Operating Cycle
 600.93 636.15 1.19K 1.11K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.10 -0.17 -0.28 -0.22 -1.30
Free Cash Flow Per Share
 -0.10 -0.17 -0.28 -0.22 -1.30
CapEx Per Share
 <0.01 <0.01 <0.01 0.00 <0.01
Free Cash Flow to Operating Cash Flow
 1.02 1.01 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -58.13 -115.76 -900.38 0.00 -12.58K
Capital Expenditure Coverage Ratio
 -58.13 -115.76 -900.38 0.00 -12.58K
Operating Cash Flow Coverage Ratio
 -0.02 -0.10 -0.16 -0.28 -2.12
Operating Cash Flow to Sales Ratio
 -0.02 -0.04 -0.12 -0.13 -63.26
Free Cash Flow Yield
-0.24%-0.58%-0.93%-1.30%-11.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 12.14 9.62 187.06 191.33 -7.16
Price-to-Sales (P/S) Ratio
 8.49 6.98 13.29 10.38 575.19
Price-to-Book (P/B) Ratio
 9.62 6.64 19.67 15.11 27.34
Price-to-Free Cash Flow (P/FCF) Ratio
 -418.77 -172.18 -107.84 -77.18 -9.09
Price-to-Operating Cash Flow Ratio
 -401.92 -173.67 -107.96 -77.18 -9.09
Price-to-Earnings Growth (PEG) Ratio
 0.01 <0.01 2.36 -1.80 0.16
Price-to-Fair Value
 9.62 6.64 19.67 15.11 27.34
Enterprise Value Multiple
 39.87 33.37 89.13 93.58 -7.43
Enterprise Value
 6.25B 4.48B 4.45B 2.44B 1.58B
EV to EBITDA
 39.87 33.37 89.13 93.58 -7.43
EV to Sales
 8.93 7.28 13.52 10.45 568.28
EV to Free Cash Flow
 -440.71 -179.45 -109.66 -77.75 -8.98
EV to Operating Cash Flow
 -448.29 -181.00 -109.78 -77.75 -8.98
Tangible Book Value Per Share
 4.04 4.49 1.53 1.13 0.43
Shareholders’ Equity Per Share
 4.04 4.49 1.53 1.13 0.43
Tax and Other Ratios
Effective Tax Rate
 -2.78 -3.16 0.09 0.03 0.00
Revenue Per Share
 4.85 4.27 2.26 1.65 0.02
Net Income Per Share
 3.20 3.10 0.16 0.09 -1.65
Tax Burden
 3.78 4.16 0.91 0.97 1.00
Interest Burden
 0.78 0.80 0.52 0.51 1.05
Research & Development to Revenue
 0.22 0.26 0.29 0.33 45.01
SG&A to Revenue
 0.36 0.38 0.47 0.53 34.29
Stock-Based Compensation to Revenue
 0.07 0.10 0.13 0.16 6.89
Income Quality
 -0.03 -0.06 -1.73 -2.48 0.89
Currency in USD